Adaptive immune response to bordetella pertussis during vaccination and infection: emerging perspectives and unanswered questions

References

• Esposito S, Stefanelli P, Fry NK, et al. Pertussis prevention: reasons for resurgence, and differences in the Current acellular pertussis vaccines. Front Immunol. 2019;10:1344. doi: 10.3389/fimmu.2019.01344
   PubMed Web of Science ®Google Scholar
• Kuehn BM. Resurgence of pertussis linked with switch to acellular vaccine. JAMA. 2021 Jul 27;326(4):300. doi: 10.1001/jama.2021.11153
   Web of Science ®Google Scholar
• Chen Z, He Q. Immune persistence after pertussis vaccination. Hum Vaccin Immunother. 2017 Apr 3;13(4):744–756. doi: 10.1080/21645515.2016.1259780
   PubMed Web of Science ®Google Scholar
• Chit A, Zivaripiran H, Shin T, et al. Acellular pertussis vaccines effectiveness over time: a systematic review, meta-analysis and modeling study. PLOS ONE. 2018;13(6):e0197970. doi: 10.1371/journal.pone.0197970
   PubMed Web of Science ®Google Scholar
• Jenkinson D. Duration of effectiveness of pertussis vaccine: evidence from a 10 year community study. Br Med J (Clin Res Ed). 1988 Feb 27;296(6622):612–614. doi: 10.1136/bmj.296.6622.612
   PubMedGoogle Scholar
• Klein NP, Bartlett J, Fireman B, et al. Comparative effectiveness of acellular versus whole-cell pertussis vaccines in teenagers. Pediatrics. 2013 Jun;131(6):e1716–22. doi: 10.1542/peds.2012-3836
   PubMed Web of Science ®Google Scholar
• Bancroft T, Dillon MB, da Silva Antunes R, et al. Th1 versus Th2 T cell polarization by whole-cell and acellular childhood pertussis vaccines persists upon re-immunization in adolescence and adulthood. Cell Immunol. 2016 Jun;304–305:35–43. doi: 10.1016/j.cellimm.2016.05.002
   PubMed Web of Science ®Google Scholar
• da Silva Antunes R, Babor M, Carpenter C, et al. Th1/Th17 polarization persists following whole-cell pertussis vaccination despite repeated acellular boosters. J Clin Invest. 2018 Aug 31;128(9):3853–3865. doi: 10.1172/JCI121309
   PubMed Web of Science ®Google Scholar
• da Silva Antunes R, Quiambao LG, Soldevila F, et al. Lack of evidence supporting a role of IFN-beta and TGF-beta in differential polarization of bordetella pertussis specific-T cell responses. Cytokine. 2021 Jan;137:155313. doi: 10.1016/j.cyto.2020.155313
   PubMed Web of Science ®Google Scholar
• Wanlapakorn N, Maertens K, Vongpunsawad S, et al. Quantity and quality of antibodies after acellular versus whole-cell pertussis vaccines in infants Born to mothers Who received tetanus, diphtheria, and acellular pertussis vaccine during pregnancy: a randomized trial. Clin Infect Dis. 2020 Jun 24;71(1):72–80. doi: 10.1093/cid/ciz778
   PubMed Web of Science ®Google Scholar
• da Silva Antunes R, Garrigan E, Quiambao LG, et al. T cell reactivity to bordetella pertussis is highly diverse regardless of childhood vaccination. Cell Host Microbe. 2023 Aug 9;31(8):1404–1416.e4. doi: 10.1016/j.chom.2023.06.015
   PubMed Web of Science ®Google Scholar
• McCarthy KN, Hone S, McLoughlin RM, et al. IL-17 and IFN-gamma-producing respiratory tissue resident memory CD4 T cells persist for decades in adults immunized as children with whole cell pertussis vaccines. J Infect Dis. 2024 Jan 30. doi: 10.1093/infdis/jiae034
   Web of Science ®Google Scholar
• da Silva Antunes R, Soldevila F, Pomaznoy M, et al. A system-view of bordetella pertussis booster vaccine responses in adults primed with whole-cell versus acellular vaccine in infancy. JCI Insight. 2021 Apr 8;6(7). doi: 10.1172/jci.insight.141023
   Web of Science ®Google Scholar
• Solans L, Locht C. The role of mucosal immunity in pertussis. Front Immunol. 2018;9:3068. doi: 10.3389/fimmu.2018.03068
   PubMed Web of Science ®Google Scholar
• Warfel JM, Zimmerman LI, Merkel TJ. Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model. Proc Natl Acad Sci USA. 2014 Jan 14;111(2):787–792. doi: 10.1073/pnas.1314688110
   PubMed Web of Science ®Google Scholar
• Wilk MM, Borkner L, Misiak A, et al. Immunization with whole cell but not acellular pertussis vaccines primes CD4 TRM cells that sustain protective immunity against nasal colonization with bordetella pertussis. Emerg Microbes Infect. 2019;8(1):169–185. doi: 10.1080/22221751.2018.1564630
   PubMed Web of Science ®Google Scholar
• Zeddeman A, van Schuppen E, Kok KE, et al. Effect of FHA and Prn on bordetella pertussis colonization of mice is dependent on vaccine type and anatomical site. PLoS One. 2020;15(8):e0237394. doi: 10.1371/journal.pone.0237394
   PubMedGoogle Scholar
• de Melker HE, Versteegh FG, Schellekens JF, et al. The incidence of bordetella pertussis infections estimated in the population from a combination of serological surveys. J Infect. 2006 Aug;53(2):106–113. doi: 10.1016/j.jinf.2005.10.020
   PubMed Web of Science ®Google Scholar
• Heininger U, Kleemann WJ, Cherry JD, et al. A controlled study of the relationship between bordetella pertussis infections and sudden unexpected deaths among German infants. Pediatrics. 2004 Jul;114(1):e9–15. doi: 10.1542/peds.114.1.e9
   PubMed Web of Science ®Google Scholar
• Naeini AE, Zaman N, Khorvash F, et al. Does working in hospital increases seroprevalence and carrier state against bordetella pertussis? Adv Biomed Res. 2015;4(1):194. doi: 10.4103/2277-9175.166155
   PubMedGoogle Scholar
• Palazzo R, Carollo M, Fedele G, et al. Evidence of increased circulation of bordetella pertussis in the Italian adult population from seroprevalence data (2012-2013). J Med Microbiol. 2016 Jul;65(7):649–657. doi: 10.1099/jmm.0.000264
   PubMed Web of Science ®Google Scholar
• Zhang Q, Yin Z, Li Y, et al. Prevalence of asymptomatic bordetella pertussis and bordetella parapertussis infections among school children in China as determined by pooled real-time PCR: a cross-sectional study. Scand J Infect Dis. 2014 Apr;46(4):280–287. doi: 10.3109/00365548.2013.878034
   PubMed Web of Science ®Google Scholar
• Gill CJ, Gunning CE, MacLeod WB, et al. Asymptomatic bordetella pertussis infections in a longitudinal cohort of young African infants and their mothers. Elife. 2021 Jun 7;10. doi: 10.7554/eLife.65663
   Web of Science ®Google Scholar
• Blanchard-Rohner G. Novel approaches to reactivate pertussis immunity. Expert Rev Vaccines. 2022 Dec;21(12):1787–1797. doi: 10.1080/14760584.2022.2149499
   PubMed Web of Science ®Google Scholar
• Chen Z, Pang J, Zhang N, et al. Seroprevalence study of pertussis in adults at childbearing age and young infants reveals the necessity of booster immunizations in adults in China. Vaccines (Basel). 2022 Jan 6;10(1):84. doi: 10.3390/vaccines10010084
   PubMed Web of Science ®Google Scholar
• von Konig CH, Halperin S, Riffelmann M, et al. Pertussis of adults and infants. Lancet Infect Dis. 2002 Dec;2(12):744–750. doi: 10.1016/S1473-3099(02)00452-8
   PubMed Web of Science ®Google Scholar
• Bagcchi S. Pertussis cases rise in Denmark. Lancet Infect Dis. 2023 Nov;23(11):e469. doi: 10.1016/S1473-3099(23)00645-X
   PubMed Web of Science ®Google Scholar
• Kardas-Nelson M. Despite high rates of vaccination, pertussis cases are on the rise. Is a new vaccination strategy needed? BMJ. 2019 Jul 9;366:l4460. doi: 10.1136/bmj.l4460
   PubMedGoogle Scholar
• Mahmud AS, Lipsitch M, Goldstein E. On the role of different age groups during pertussis epidemics in California, 2010 and 2014. Epidemiol Infect. 2019 Jan;147:e184. doi: 10.1017/S0950268819000761
   PubMed Web of Science ®Google Scholar
• Smout E, Mellon D, Rae M. Whooping cough rises sharply in UK and Europe. BMJ. 2024 Apr 2;385:q736. doi: 10.1136/bmj.q736
   PubMedGoogle Scholar
• Wearing HJ, Rohani P, Levin BR. Estimating the duration of pertussis immunity using epidemiological signatures. PloS Pathog. 2009 Oct;5(10):e1000647. doi: 10.1371/journal.ppat.1000647
   PubMed Web of Science ®Google Scholar
• Wirsing von Konig CH, Postels-Multani S, Bock HL, et al. Pertussis in adults: frequency of transmission after household exposure. Lancet. 1995 Nov 18;346(8986):1326–1329. doi: 10.1016/S0140-6736(95)92343-8
   PubMed Web of Science ®Google Scholar
• Keech C, Miller VE, Rizzardi B, et al. Immunogenicity and safety of BPZE1, an intranasal live attenuated pertussis vaccine, versus tetanus-diphtheria-acellular pertussis vaccine: a randomised, double-blind, phase 2b trial. Lancet. 2023 Mar 11;401(10379):843–855. doi: 10.1016/S0140-6736(22)02644-7
   PubMed Web of Science ®Google Scholar
• Gregg KA, Wang Y, Warfel J, et al. Antigen discovery for next-generation pertussis vaccines using immunoproteomics and transposon-directed insertion sequencing. J Infect Dis. 2023 Feb 14;227(4):583–591. doi: 10.1093/infdis/jiac502
   PubMed Web of Science ®Google Scholar
• Raeven RH, van der Maas L, Tilstra W, et al. Immunoproteomic profiling of bordetella pertussis outer membrane vesicle vaccine reveals broad and balanced humoral immunogenicity. J Proteome Res. 2015 Jul 2;14(7):2929–2942. doi: 10.1021/acs.jproteome.5b00258
   PubMed Web of Science ®Google Scholar
• Lin A, Apostolovic D, Jahnmatz M, et al. Live attenuated pertussis vaccine BPZE1 induces a broad antibody response in humans. J Clin Invest. 2020 May 1;130(5):2332–2346. doi: 10.1172/JCI135020
   PubMed Web of Science ®Google Scholar
• Natrajan MS, Hall JM, Weigand MR, et al. Genome-based prediction of cross-protective, HLA-DR-presented epitopes as putative vaccine antigens for multiple bordetella species. Microbiol Spectr. 2024 Jan 11;12(1):e0352723. doi: 10.1128/spectrum.03527-23
   PubMed Web of Science ®Google Scholar
• Boehm DT, Hall JM, Wong TY, et al. Evaluation of adenylate cyclase toxoid antigen in acellular pertussis vaccines by using a bordetella pertussis challenge Model in mice. Infect Immun. 2018 Oct;86(10). doi: 10.1128/IAI.00857-17
   PubMed Web of Science ®Google Scholar
• Liang JL, Tiwari T, Moro P, et al. Prevention of pertussis, tetanus, and diphtheria with vaccines in the United States: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep. 2018 Apr 27;67(2):1–44. doi: 10.15585/mmwr.rr6702a1
   PubMed Web of Science ®Google Scholar
• Hviid A, Stellfeld M, Andersen PH, et al. Impact of routine vaccination with a pertussis toxoid vaccine in Denmark. Vaccine. 2004 Sep 9;22(27–28):3530–3534. doi: 10.1016/j.vaccine.2004.03.046
   PubMed Web of Science ®Google Scholar
• Liu TC, Zhang J, Liu SQ, et al. Evaluation of immunisation strategies for pertussis vaccines in Jinan, China - an interrupted time-series study. Epidemiol Infect. 2020 Feb 12;148:e26. doi: 10.1017/S0950268820000102
   PubMed Web of Science ®Google Scholar
• Poltorak V, Cabre-Riera A, Martinez-Botias F, et al. Increase of pertussis cases in the Valles region, Catalonia, Spain, September 2023 to April 2024. Euro Surveill. 2024 Jun;29(24). doi: 10.2807/1560-7917.ES.2024.29.24.2400332
   PubMedGoogle Scholar
• Nordholm AC, Emborg HD, Norgaard SK, et al. Pertussis epidemic in Denmark, August 2023 to February 2024. Euro Surveill. 2024 Apr;29(14). doi: 10.2807/1560-7917.ES.2024.29.14.2400160
   Google Scholar
• Hu Y, Guo M, Yao K. Infections in preschool and school-aged children are driving the recent rise in pertussis in China. J Infect. 2024 Jun;88(6):106170. doi: 10.1016/j.jinf.2024.106170
   PubMed Web of Science ®Google Scholar
• Liu Y, Ye Q. Resurgence and the shift in the age of peak onset of pertussis in southern China. J Infect. 2024 Jun 1;89(2):106194. doi: 10.1016/j.jinf.2024.106194
   PubMed Web of Science ®Google Scholar
• Althouse BM, Scarpino SV. Asymptomatic transmission and the resurgence of bordetella pertussis. BMC Med. 2015 Jun 24;13:146. doi: 10.1186/s12916-015-0382-8
   PubMed Web of Science ®Google Scholar
• Craig R, Kunkel E, Crowcroft NS, et al. Asymptomatic infection and transmission of pertussis in households: a systematic review. Clin Infect Dis. 2020 Jan 1;70(1):152–161. doi: 10.1093/cid/ciz531
   PubMed Web of Science ®Google Scholar
• Nakayama T, Suzuki E, Noda A. Vaccine acquired pertussis immunity was weakened at 4 years of age and asymptomatic pertussis infection was suspected based on serological surveillance. J Infect Chemother. 2019 Aug;25(8):643–645. doi: 10.1016/j.jiac.2019.03.027
   PubMed Web of Science ®Google Scholar
• Warfel JM, Merkel TJ. The baboon model of pertussis: effective use and lessons for pertussis vaccines. Expert Rev Vaccines. 2014 Oct;13(10):1241–1252. doi: 10.1586/14760584.2014.946016
   PubMed Web of Science ®Google Scholar
• Hendrikx LH, Schure RM, Ozturk K, et al. Different IgG-subclass distributions after whole-cell and acellular pertussis infant primary vaccinations in healthy and pertussis infected children. Vaccine. 2011 Sep 16;29(40):6874–6880. doi: 10.1016/j.vaccine.2011.07.055
   PubMed Web of Science ®Google Scholar
• Schure RM, Hendrikx LH, de Rond LG, et al. Differential T- and B-cell responses to pertussis in acellular vaccine-primed versus whole-cell vaccine-primed children 2 years after preschool acellular booster vaccination. Clin Vaccine Immunol. 2013 Sep;20(9):1388–1395. doi: 10.1128/CVI.00270-13
   PubMedGoogle Scholar
• van der Lee S, Hendrikx LH, Sanders EAM, et al. Whole-cell or acellular pertussis primary immunizations in infancy determines adolescent cellular immune profiles. Front Immunol. 2018;9:51. doi: 10.3389/fimmu.2018.00051
   PubMed Web of Science ®Google Scholar
• Domenech de Celles M, Rohani P, King AA. Duration of immunity and effectiveness of diphtheria-tetanus-acellular pertussis vaccines in children. JAMA Pediatr. 2019 Jun 1;173(6):588–594. doi: 10.1001/jamapediatrics.2019.0711
   PubMed Web of Science ®Google Scholar
• Damron FH, Barbier M, Dubey P, et al. Overcoming waning immunity in pertussis vaccines: workshop of the national institute of allergy and infectious diseases. J Immunol. 2020 Aug 15;205(4):877–882. doi: 10.4049/jimmunol.2000676
   PubMed Web of Science ®Google Scholar
• McAlister SM, van den Biggelaar AHJ, Woodman TL, et al. An observational study of antibody responses to a primary or subsequent pertussis booster vaccination in Australian healthcare workers. Vaccine. 2021 Mar 12;39(11):1642–1651. doi: 10.1016/j.vaccine.2021.01.041
   PubMed Web of Science ®Google Scholar
• Versteegen P, Valente Pinto M, Barkoff AM, et al. Responses to an acellular pertussis booster vaccination in children, adolescents, and young and older adults: a collaborative study in Finland, the Netherlands, and the United Kingdom. EBioMedicine. 2021 Mar;65:103247. doi: 10.1016/j.ebiom.2021.103247
   PubMed Web of Science ®Google Scholar
• Yu ED, Narowski TM, Wang E, et al. Immunological memory to common cold coronaviruses assessed longitudinally over a three-year period pre-COVID19 pandemic. Cell Host Microbe. 2022 Sep 14;30(9):1269–1278 e4. doi: 10.1016/j.chom.2022.07.012
   PubMed Web of Science ®Google Scholar
• Heininger U, Andre P, Chlibek R, et al. Comparative epidemiologic characteristics of pertussis in 10 central and eastern European countries, 2000-2013. PLOS ONE. 2016;11(6):e0155949. doi: 10.1371/journal.pone.0155949
   PubMed Web of Science ®Google Scholar
• Macina D, Evans KE. Bordetella pertussis in school-age children, adolescents, and adults: a systematic review of epidemiology, burden, and mortality in Asia. Infect Dis Ther. 2021 Sep;10(3):1115–1140. doi: 10.1007/s40121-021-00439-1
   PubMed Web of Science ®Google Scholar
• Berbers G, van Gageldonk P, Kassteele JV, et al. Circulation of pertussis and poor protection against diphtheria among middle-aged adults in 18 European countries. Nat Commun. 2021 May 17;12(1):2871. doi: 10.1038/s41467-021-23114-y
   PubMed Web of Science ®Google Scholar
• Wehlin L, Ljungman M, Kuhlmann-Berenzon S, et al. Pertussis seroprevalence among adults of reproductive age (20-39 years) in fourteen European countries. APMIS. 2021 Sep;129(9):556–565. doi: 10.1111/apm.13165
   PubMed Web of Science ®Google Scholar
• Guzman-Holst A, Gomez JA, Cintra O, et al. Assessing the underestimation of adult pertussis disease in five Latin American countries. Infect Dis Ther. 2023 Dec;12(12):2791–2806. doi: 10.1007/s40121-023-00895-x
   PubMed Web of Science ®Google Scholar
• Koh MT, Liu CS, Chiu CH, et al. Under-recognized pertussis in adults from Asian countries: a cross-sectional seroprevalence study in Malaysia, Taiwan and Thailand. Epidemiol Infect. 2016 Apr;144(6):1192–1200. doi: 10.1017/S0950268815002393
   PubMed Web of Science ®Google Scholar
• Kardos P, Correia de Sousa J, Heininger U, et al. Understanding the impact of adult pertussis and current approaches to vaccination: a narrative review and expert panel recommendations. Hum Vaccin Immunother. 2024 Dec 31;20(1):2324547. doi: 10.1080/21645515.2024.2324547
   PubMed Web of Science ®Google Scholar
• Ahvenainen N, Dub T, Knuutila A, et al. Widespread circulation of pertussis in Finland during 1968-1972 when the whole cell vaccine was in use. Clin Microbiol Infect. 2021 Oct;27(10):1526–1528. doi: 10.1016/j.cmi.2021.06.014
   PubMed Web of Science ®Google Scholar
• Barkoff AM, Grondahl-Yli-Hannuksela K, He Q, et al. Seroprevalence studies of pertussis: what have we learned from different immunized populations. Pathog Dis. 2015 Oct;73(7):ftv050. doi: 10.1093/femspd/ftv050
   PubMed Web of Science ®Google Scholar
• Pebody RG, Gay NJ, Giammanco A, et al. The seroepidemiology of bordetella pertussis infection in Western Europe. Epidemiol Infect. 2005 Feb;133(1):159–171. doi: 10.1017/S0950268804003012
   PubMed Web of Science ®Google Scholar
• Harrington L, Aris E, Bhavsar A, et al. Burden of pertussis in adults aged 50 years and older: a retrospective database study in England. Infect Dis Ther. 2023 Apr;12(4):1103–1118. doi: 10.1007/s40121-023-00774-5
   PubMed Web of Science ®Google Scholar
• Masseria C, Krishnarajah G. The estimated incidence of pertussis in people aged 50 years old in the United States, 2006–2010. BMC Infect Dis. 2015 Nov 19;15:534. doi: 10.1186/s12879-015-1269-1
   PubMed Web of Science ®Google Scholar
• Katfy K, Diawara I, Maaloum F, et al. Pertussis in infants, in their mothers and other contacts in Casablanca, Morocco. BMC Infect Dis. 2020 Jan 14;20(1):43. doi: 10.1186/s12879-019-4680-1
   PubMed Web of Science ®Google Scholar
• Wendelboe AM, Njamkepo E, Bourillon A, et al. Transmission of bordetella pertussis to young infants. Pediatr Infect Dis J. 2007 Apr;26(4):293–299. doi: 10.1097/01.inf.0000258699.64164.6d
   PubMed Web of Science ®Google Scholar
• Wiley KE, Zuo Y, Macartney KK, et al. Sources of pertussis infection in young infants: a review of key evidence informing targeting of the cocoon strategy. Vaccine. 2013 Jan 11;31(4):618–625. doi: 10.1016/j.vaccine.2012.11.052
   PubMed Web of Science ®Google Scholar
• Arakkal AT, Cavanaugh JE, Polgreen PM, et al. The increase in household transmission of pertussis associated with diagnostic delays. Pediatr Infect Dis J. 2024 Mar 25;43(7):614–619. doi: 10.1097/INF.0000000000004302
   PubMed Web of Science ®Google Scholar
• Kandeil W, Atanasov P, Avramioti D, et al. The burden of pertussis in older adults: what is the role of vaccination? A systematic literature review. Expert Rev Vaccines. 2019 May;18(5):439–455. doi: 10.1080/14760584.2019.1588727
   PubMed Web of Science ®Google Scholar
• Macina D, Evans KE. Pertussis in individuals with Co-morbidities: a systematic review. Infect Dis Ther. 2021 Sep;10(3):1141–1170. doi: 10.1007/s40121-021-00465-z
   PubMed Web of Science ®Google Scholar
• Wilkinson TMA, Van den Steen P, Cheuvart B, et al. Seroprevalence of bordetella pertussis infection in patients with chronic obstructive pulmonary disease in England: analysis of the AERIS cohort. COPD: J Chronic Obstr Pulm Disease. 2021 Jun;18(3):341–348. doi: 10.1080/15412555.2021.1920904
   PubMed Web of Science ®Google Scholar
• Matheson GO, Clement DB, McKenzie DC, et al. Stress fractures in athletes. A study of 320 cases. Am J Sports Med. 1987 Jan;15(1):46–58. doi: 10.1177/036354658701500107
   PubMed Web of Science ®Google Scholar
• Pearce R, Chen J, Chin KL, et al. Population-based study of pertussis incidence and risk factors among persons >50 years of age, Australia. Emerg Infect Dis. 2024 Jan;30(1):105–115. doi: 10.3201/eid3001.230261
   PubMed Web of Science ®Google Scholar
• Lambert EE, van Twillert I, Beckers L, et al. Reduced bordetella pertussis-specific CD4(+) T-Cell responses at older age. Front Aging. 2021;2:737870. doi: 10.3389/fragi.2021.737870
   PubMedGoogle Scholar
• Choi JH, Correia de Sousa J, Fletcher M, et al. Improving vaccination rates in older adults and at-risk groups: focus on pertussis. Aging Clin Exp Res. 2022 Jan;34(1):1–8. doi: 10.1007/s40520-021-02018-3
   PubMed Web of Science ®Google Scholar
• Kuncio DE, Middleton M, Cooney MG, et al. Health care worker exposures to pertussis: missed opportunities for prevention. Pediatrics. 2014 Jan;133(1):15–21. doi: 10.1542/peds.2013-0745
   PubMed Web of Science ®Google Scholar
• Sandora TJ, Gidengil CA, Lee GM. Pertussis vaccination for health care workers. Clin Microbiol Rev. 2008 Jul;21(3):426–434. doi: 10.1128/CMR.00003-08
   PubMed Web of Science ®Google Scholar
• Jan-Willem V, Nicolas J, Ken R. Cost of illness due to pertussis in adults >/=50 years of age in the United Kingdom. Vaccine. 2023 Oct 13;41(47):6991–6998. doi: 10.1016/j.vaccine.2023.10.010
   PubMed Web of Science ®Google Scholar
• McGuiness CB, Hill J, Fonseca E, et al. The disease burden of pertussis in adults 50 years old and older in the United States: a retrospective study. BMC Infect Dis. 2013 Jan 23;13:32. doi: 10.1186/1471-2334-13-32
   PubMed Web of Science ®Google Scholar
• Lee AD, Cassiday PK, Pawloski LC, et al. Clinical evaluation and validation of laboratory methods for the diagnosis of bordetella pertussis infection: culture, polymerase chain reaction (PCR) and anti-pertussis toxin IgG serology (IgG-PT). PLoS One. 2018;13(4):e0195979. doi: 10.1371/journal.pone.0195979
   PubMed Web of Science ®Google Scholar
• de Graaf H, Ibrahim M, Hill AR, et al. Controlled human infection with bordetella pertussis induces asymptomatic, immunizing colonization. Clin Infect Dis. 2020 Jul 11;71(2):403–411. doi: 10.1093/cid/ciz840
   PubMed Web of Science ®Google Scholar
• Warfel JM, Zimmerman LI, Merkel TJ, et al. Comparison of three whole-cell pertussis vaccines in the baboon Model of pertussis. Clin Vaccine Immunol. 2016 Jan;23(1):47–54. doi: 10.1128/CVI.00449-15
   PubMedGoogle Scholar
• Vincart B, De Mendonca R, Rottiers S, et al. A specific real-time PCR assay for the detection of bordetella pertussis. J Med Microbiol. 2007 Jul;56(Pt 7):918–920. doi: 10.1099/jmm.0.46947-0
   PubMed Web of Science ®Google Scholar
• Zhang RQ, Li Z, Li GX, et al. A highly sensitive one-tube nested quantitative real-time PCR assay for specific detection of bordetella pertussis using the LNA technique. Int J Infect Dis. 2020 Apr;93:224–230. doi: 10.1016/j.ijid.2020.01.053
   PubMed Web of Science ®Google Scholar
• de Melker HE, Versteegh FG, Conyn-Van Spaendonck MA, et al. Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with bordetella pertussis. J Clin Microbiol. 2000 Feb;38(2):800–806. doi: 10.1128/JCM.38.2.800-806.2000
   PubMed Web of Science ®Google Scholar
• Campbell H, Amirthalingam G, Fry NK, et al. Oral fluid testing for pertussis, England and wales, June 2007-August 2009. Emerg Infect Dis. 2014 Jun;20(6):968–975. doi: 10.3201/eid2006.131069
   PubMed Web of Science ®Google Scholar
• Grassi T, Bagordo F, Savio M, et al. Sero-epidemiological study of bordetella pertussis infection in the Italian General population. Vaccines (Basel). 2022 Dec 13;10(12):2130. doi: 10.3390/vaccines10122130
   PubMed Web of Science ®Google Scholar
• Kurova N, Timofeeva EV, Guiso N, et al. A cross-sectional study of bordetella pertussis seroprevalence and estimated duration of vaccine protection against pertussis in st. Petersburg, Russia. Vaccine. 2018 Dec 18;36(52):7936–7942. doi: 10.1016/j.vaccine.2018.11.007
   PubMed Web of Science ®Google Scholar
• van Schuppen E, Froberg J, Venkatasubramanian PB, et al. Prior exposure to B. pertussis shapes the mucosal antibody response to acellular pertussis booster vaccination. Nat Commun. 2022 Dec 2;13(1):7429. doi: 10.1038/s41467-022-35165-w
   PubMed Web of Science ®Google Scholar
• Subissi L, Rodeghiero C, Martini H, et al. Assessment of IgA anti-PT and IgG anti-ACT reflex testing to improve bordetella pertussis serodiagnosis in recently vaccinated subjects. Clin Microbiol Infect. 2020 May;26(5):645 e1–645 e8. doi: 10.1016/j.cmi.2019.10.001
   PubMed Web of Science ®Google Scholar
• Gallais F, Velay A, Nazon C, et al. Intrafamilial exposure to SARS-CoV-2 associated with cellular immune response without seroconversion, France. Emerg Infect Dis. 2021 Jan;27(1):113–121. doi: 10.3201/eid2701.203611
   PubMed Web of Science ®Google Scholar
• Pollock KM, Whitworth HS, Montamat-Sicotte DJ, et al. T-cell immunophenotyping distinguishes active from latent tuberculosis. J Infect Dis. 2013 Sep;208(6):952–968. doi: 10.1093/infdis/jit265
   PubMed Web of Science ®Google Scholar
• Yu ED, Wang E, Garrigan E, et al. Development of a T cell-based immunodiagnostic system to effectively distinguish SARS-CoV-2 infection and COVID-19 vaccination status. Cell Host Microbe. 2022 Mar 9;30(3):388–399 e3. doi: 10.1016/j.chom.2022.02.003
   PubMed Web of Science ®Google Scholar
• da Silva Antunes R, Quiambao LG, Sutherland A, et al. Development and validation of a bordetella pertussis whole-genome screening strategy. J Immunol Res. 2020;2020:1–11. doi: 10.1155/2020/8202067
   Web of Science ®Google Scholar
• Plotkin SA. Correlates of protection induced by vaccination. Clin Vaccine Immunol. 2010 Jul;17(7):1055–1065. doi: 10.1128/CVI.00131-10
   PubMed Web of Science ®Google Scholar
• Cassone A, Mastrantonio P, Ausiello CM. Are only antibody levels involved in the protection against pertussis in acellular pertussis vaccine recipients? J Infect Dis. 2000 Nov;182(5):1575–1577. doi: 10.1086/315898
   PubMed Web of Science ®Google Scholar
• Fedele G, Cassone A, Ausiello CM., Carbonetti, N. T-cell immune responses to bordetella pertussis infection and vaccination: graphical abstract figure. Pathog Dis. 2015 Oct;73(7):ftv051. doi: 10.1093/femspd/ftv051
   PubMed Web of Science ®Google Scholar
• Saso A, Kampmann B, Roetynck S. Vaccine-induced cellular immunity against bordetella pertussis: harnessing lessons from animal and human studies to improve design and testing of novel pertussis vaccines. Vaccines (Basel). 2021 Aug 7;9(8):877. doi: 10.3390/vaccines9080877
   PubMed Web of Science ®Google Scholar
• Misiak A, Wilk MM, Raverdeau M, et al. IL-17-Producing innate and pathogen-specific tissue resident Memory gammadelta T cells expand in the lungs of bordetella pertussis-infected mice. J Immunol. 2017 Jan 1;198(1):363–374. doi: 10.4049/jimmunol.1601024
   PubMed Web of Science ®Google Scholar
• Solans L, Debrie AS, Borkner L, et al. IL-17-dependent SIgA-mediated protection against nasal bordetella pertussis infection by live attenuated BPZE1 vaccine. Mucosal Immunol. 2018 Nov;11(6):1753–1762. doi: 10.1038/s41385-018-0073-9
   PubMed Web of Science ®Google Scholar
• Wilk MM, Misiak A, McManus RM, et al. Lung CD4 tissue-resident memory T cells mediate adaptive immunity induced by previous infection of mice with bordetella pertussis. J Immunol. 2017 Jul 1;199(1):233–243. doi: 10.4049/jimmunol.1602051
   PubMed Web of Science ®Google Scholar
• Higgs R, Higgins SC, Ross PJ, et al. Immunity to the respiratory pathogen bordetella pertussis. Mucosal Immunol. 2012 Sep;5(5):485–500. doi: 10.1038/mi.2012.54
   PubMed Web of Science ®Google Scholar
• Burdin N, Handy LK, Plotkin SA. What is wrong with pertussis vaccine immunity? The problem of waning effectiveness of pertussis vaccines. Cold Spring Harb Perspect Biol. 2017 Dec 1;9(12):a029454. doi: 10.1101/cshperspect.a029454
   PubMed Web of Science ®Google Scholar
• Diavatopoulos DA, Edwards KM. What is wrong with pertussis vaccine immunity? Why immunological memory to pertussis is failing. Cold Spring Harb Perspect Biol. 2017 Dec 1;9(12):a029553. doi: 10.1101/cshperspect.a029553
   PubMed Web of Science ®Google Scholar
• Rowe J, Yerkovich ST, Richmond P, et al. Th2-associated local reactions to the acellular diphtheria-tetanus-pertussis vaccine in 4- to 6-year-old children. Infect Immun. 2005 Dec;73(12):8130–8135. doi: 10.1128/IAI.73.12.8130-8135.2005
   PubMed Web of Science ®Google Scholar
• Ryan M, Murphy G, Ryan E, et al. Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children. Immunology. 1998 Jan;93(1):1–10. doi: 10.1046/j.1365-2567.1998.00401.x
   PubMed Web of Science ®Google Scholar
• van der Lee S, van Rooijen DM, de Zeeuw-Brouwer ML, et al. Robust humoral and cellular immune responses to pertussis in adults after a first acellular booster vaccination. Front Immunol. 2018;9:681. doi: 10.3389/fimmu.2018.00681
   PubMed Web of Science ®Google Scholar
• Warfel JM, Merkel TJ. Bordetella pertussis infection induces a mucosal IL-17 response and long-lived Th17 and Th1 immune memory cells in nonhuman primates. Mucosal Immunol. 2013 Jul;6(4):787–796. doi: 10.1038/mi.2012.117
   PubMed Web of Science ®Google Scholar
• Kapil P, Wang Y, Zimmerman L, et al. Repeated B. pertussis infections are required to reprogram acellular pertussis vaccine-primed Host responses in the baboon Model. J Infect Dis. 2023 Aug 11;229(2):376–383. doi: 10.1093/infdis/jiad332
   Web of Science ®Google Scholar
• Allen AC, Wilk MM, Misiak A, et al. Sustained protective immunity against bordetella pertussis nasal colonization by intranasal immunization with a vaccine-adjuvant combination that induces IL-17-secreting T(RM) cells. Mucosal Immunol. 2018 Nov;11(6):1763–1776. doi: 10.1038/s41385-018-0080-x
   PubMed Web of Science ®Google Scholar
• Dubois V, Chatagnon J, Thiriard A, et al. Suppression of mucosal Th17 memory responses by acellular pertussis vaccines enhances nasal bordetella pertussis carriage. NPJ Vaccines. 2021 Jan 8;6(1):6. doi: 10.1038/s41541-020-00270-8
   PubMed Web of Science ®Google Scholar
• Yount KS, Hall JM, Caution K, et al. Systemic priming and intranasal booster with a BcfA-adjuvanted acellular pertussis vaccine generates CD4+ IL-17+ nasal tissue resident T cells and reduces B. pertussis nasal colonization. Front Immunol. 2023;14:1181876. doi: 10.3389/fimmu.2023.1181876
   PubMed Web of Science ®Google Scholar
• Wendelboe AM, Van Rie A, Salmaso S, et al. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J. 2005 May;24(5 Suppl):S58–61. doi: 10.1097/01.inf.0000160914.59160.41
   PubMedGoogle Scholar
• Dalby T, Petersen JW, Harboe ZB, et al. Antibody responses to pertussis toxin display different kinetics after clinical bordetella pertussis infection than after vaccination with an acellular pertussis vaccine. J Med Microbiol. 2010 Sep;59(Pt 9):1029–1036. doi: 10.1099/jmm.0.020826-0
   PubMed Web of Science ®Google Scholar
• Heininger U, Cherry JD, Stehr K. Serologic response and antibody-titer decay in adults with pertussis. Clin Infect Dis. 2004 Feb 15;38(4):591–594. doi: 10.1086/381439
   PubMed Web of Science ®Google Scholar
• Le T, Cherry JD, Chang SJ, et al. Immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine: the APERT study. J Infect Dis. 2004 Aug 1;190(3):535–544. doi: 10.1086/422035
   PubMed Web of Science ®Google Scholar
• Ausiello CM, Lande R, la Sala A, et al. Cell-mediated immune response of healthy adults to bordetella pertussis vaccine antigens. J Infect Dis. 1998 Aug;178(2):466–470. doi: 10.1086/515628
   PubMed Web of Science ®Google Scholar
• Ausiello CM, Lande R, Urbani F, et al. Cell-mediated immunity and antibody responses to bordetella pertussis antigens in children with a history of pertussis infection and in recipients of an acellular pertussis vaccine. J Infect Dis. 2000 Jun;181(6):1989–1995. doi: 10.1086/315509
   PubMed Web of Science ®Google Scholar
• Dirix V, Verscheure V, Vermeulen F, et al. Both CD4 + and CD8 + lymphocytes participate in the IFN-γ response to filamentous hemagglutinin from bordetella pertussis in infants, children, and adults. Clin Dev Immunol. 2012;2012:1–9. doi: 10.1155/2012/795958
   Google Scholar
• He Q, Viljanen MK, Arvilommi H, et al. Whooping cough caused by bordetella pertussis and bordetella parapertussis in an immunized population. JAMA. 1998 Aug 19;280(7):635–637. doi: 10.1001/jama.280.7.635
   PubMed Web of Science ®Google Scholar
• Mascart F, Verscheure V, Malfroot A, et al. Bordetella pertussis infection in 2-month-old infants promotes type 1 T cell responses. J Immunol. 2003 Feb 1;170(3):1504–1509. doi: 10.4049/jimmunol.170.3.1504
   PubMed Web of Science ®Google Scholar
• Han WG, van Twillert I, Poelen MC, et al. Loss of multi-epitope specificity in memory CD4(+) T cell responses to B. pertussis with age. PLOS ONE. 2013;8(12):e83583. doi: 10.1371/journal.pone.0083583
   PubMed Web of Science ®Google Scholar
• Goodman YE, Wort AJ, Jackson FL. Enzyme-linked immunosorbent assay for detection of pertussis immunoglobulin a in nasopharyngeal secretions as an indicator of recent infection. J Clin Microbiol. 1981 Feb;13(2):286–292. doi: 10.1128/jcm.13.2.286-292.1981
   PubMed Web of Science ®Google Scholar
• Chen Z, Liu X, Zhang Y, et al. Evaluation of serum anti-pertussis toxin IgA antibodies for the diagnosis of bordetella pertussis infection in young children. J Infect Public Health. 2023 Aug;16(8):1167–1173. doi: 10.1016/j.jiph.2023.05.028
   PubMed Web of Science ®Google Scholar
• Jahnmatz M, Richert L, Al-Tawil N, et al. Safety and immunogenicity of the live attenuated intranasal pertussis vaccine BPZE1: a phase 1b, double-blind, randomised, placebo-controlled dose-escalation study. Lancet Infect Dis. 2020 Nov;20(11):1290–1301. doi: 10.1016/S1473-3099(20)30274-7
   PubMed Web of Science ®Google Scholar
• Nagel J, Poot-Scholtens EJ. Serum IgA antibody to bordetella pertussis as an indicator of infection. J Med Microbiol. 1983 Nov;16(4):417–426. doi: 10.1099/00222615-16-4-417
   PubMed Web of Science ®Google Scholar
• Decker MD, Edwards KM. Pertussis (whooping cough). J Infect Dis. 2021 Sep 30;224(12 Suppl 2):S310–S320. doi: 10.1093/infdis/jiaa469
   PubMedGoogle Scholar
• Basha S, Surendran N, Pichichero M. Immune responses in neonates. Expert Rev Clin Immunol. 2014 Sep;10(9):1171–1184. doi: 10.1586/1744666X.2014.942288
   PubMed Web of Science ®Google Scholar
• Zaghouani H, Hoeman CM, Adkins B. Neonatal immunity: faulty T-helpers and the shortcomings of dendritic cells. Trends Immunol. 2009 Dec;30(12):585–591. doi: 10.1016/j.it.2009.09.002
   PubMed Web of Science ®Google Scholar
• Ryan M, Murphy G, Gothefors L, et al. Bordetella pertussis respiratory infection in children is associated with preferential activation of type 1 T helper cells. J Infect Dis. 1997 May;175(5):1246–1250. doi: 10.1086/593682
   PubMed Web of Science ®Google Scholar